drugset / Trial / NCT05228899
Zofin to Treat COVID-19 Long Haulers
RandomizedSingle-groupTriple-blindTreatment
Summary
The purpose of this study is to assess the safety and potential efficacy of Zofin administered intravenously in subjects experiencing prolonged symptoms (\> 6 weeks and \< 24 months) of COVID-19.
Timeline
- Start
- 2022-04-14
- Primary completion
- 2023-10-01
- Completion
- 2023-10-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zofin | Other / unclassified | 1 ml | Intravenous |